Corrigendum to “Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo” (Biomedicine & Pharmacotherapy (2019) 116, (S0753332219317512), (10.1016/j.biopha.2019.109032))

Mao Chi Weng, Ming Hsin Li, Jing Gung Chung, Yu Chang Liu, Wu Jeng-Yuan, Fei Ting Hsu, Hsin Ell Wang

研究成果: 期刊稿件評論/辯論

指紋

深入研究「Corrigendum to “Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo” (Biomedicine & Pharmacotherapy (2019) 116, (S0753332219317512), (10.1016/j.biopha.2019.109032))」主題。共同形成了獨特的指紋。

Pharmacology, Toxicology and Pharmaceutical Science